UC Patients May Have New Treatment Options, Thanks To New, Experimental Drugs

UC Patients May Have New Treatment Options, Thanks To New, Experimental Drugs
UC therapiesPatients suffering from ulcerative colitis (UC) now have access to new therapies for treating their disease. According to UC expert William J. Sandborn, chief of the Division of Gastroenterology at the University of California, as reported in a recent issue of Healio Gastroenterologyeffective drugs for UC have been released in recent years, and more are currently being tested. “It’s never a good time to have UC, but compared to years past, there are some new treatment options and a lot more in the pipeline that give patients options they didn’t have before,” said Sandborn, referring to the wide range of tumor necrosis factor-alpha antagonist treatments recently released, which help UC patients avoid using steroids as first treatment options. “We’ve had three anti-TNF drugs approved over the last 9 years. That’s a big advancement for the treatment of UC,” he added. The advancement of these new therapies for Ulcerative Colitis, according to Sandborn, also hinges on how versatile new therapies are in treating the disease, since not everyone reacts the same way to the same treatment. According to author Shirley Pulawski at
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *